0.10Open0.10Pre Close0 Volume127 Open Interest3.00Strike Price0.00Turnover1846.26%IV2114.29%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier12DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.8070Delta0.5609Gamma1.40Leverage Ratio-0.0055Theta0.0000Rho1.13Eff Leverage0.0001Vega
FSD Pharma Stock Discussion
FSD Pharma, Inc., a biopharmaceutical company known for its dedication to the development of innovative treatments for neurodegenerative and metabolic disorders as well as alcohol misuse disorders, recently emerged victor...
GARBAGE
$LandBridge(LB.US)$
FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
FSD Pharma has received Institutional Review Board (IRB) approval for its METAL-2 trial in the USA to study the safety and efficacy of Unbuzzd(TM) in acute alcohol intoxication. This approval allows the company to begin recruiting participants and planning the clinical study. Dr. Andrzej Chruscinski, Vice-President of Clinical and Scienti...
FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
No comment yet